These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 5162747)

  • 1. Anti-substitution law repeal--pro and con: the case against repeal.
    Perloff MM
    Am J Pharm Sci Support Public Health; 1971; 143(1):15-23. PubMed ID: 5162747
    [No Abstract]   [Full Text] [Related]  

  • 2. New York's generic drug substitution law.
    Kamen A
    N Y State Dent J; 1980 Nov; 46(9):599-604. PubMed ID: 6935574
    [No Abstract]   [Full Text] [Related]  

  • 3. Mislabeling and patient liability issues for pharmacists.
    Fink JL
    Contemp Pharm Pract; 1981; 4(4):207-10. PubMed ID: 10256892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generic substitution becomes law.
    Mo Med; 1978 Sep; 75(9):467. PubMed ID: 703753
    [No Abstract]   [Full Text] [Related]  

  • 5. Generic substitution laws--physicians' liability.
    Trout ME
    J Leg Med (N Y); 1977 Jul; 5(7):14-6. PubMed ID: 301915
    [No Abstract]   [Full Text] [Related]  

  • 6. Brand substitution the consumer's viewpoint.
    Nelson AA; Gagnon JP
    J Am Pharm Assoc; 1975 Jul; 15(7):382-5, 91. PubMed ID: 1133442
    [No Abstract]   [Full Text] [Related]  

  • 7. Testimony before the South Carolina state pharmacy board in opposition to repeal of the anti-substitution regulation December 3, 1975.
    Ball FM
    J S C Med Assoc; 1976 Apr; 72(4):130-1. PubMed ID: 1063280
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug product selection legislation: a comparative analysis.
    Wetherbee H; Sharpe TR
    Am J Pharm Sci Support Public Health; 1978; 150(6):171-6. PubMed ID: 576098
    [No Abstract]   [Full Text] [Related]  

  • 9. Plan defeated, but pharmacists still seek ability to prescribe.
    Carrell S
    Am Med News; 1982 May; 25(18):3, 9. PubMed ID: 10324199
    [No Abstract]   [Full Text] [Related]  

  • 10. Generic drug equivalents: opening Pandora's Rx.
    Regulation; 1979; 3(3):4-5. PubMed ID: 10242344
    [No Abstract]   [Full Text] [Related]  

  • 11. Forces and direction of drug product selection legislation.
    Stewart JE
    Med Mark Media; 1979 Jun; 14(6):34-6, 38-9. PubMed ID: 10242281
    [No Abstract]   [Full Text] [Related]  

  • 12. More on genetic substitution.
    Luger S; Culkin TT
    J Med Soc N J; 1979 Jun; 76(6):477. PubMed ID: 287818
    [No Abstract]   [Full Text] [Related]  

  • 13. The real costs of generic substitution.
    Ballin JC
    N Y State J Med; 1988 Mar; 88(3):121-2. PubMed ID: 3357610
    [No Abstract]   [Full Text] [Related]  

  • 14. Substitution--the New York State experience.
    DeNuzzo RV
    Med Mark Media; 1981 Jan; 16(1):25-9. PubMed ID: 10249801
    [No Abstract]   [Full Text] [Related]  

  • 15. The Ohio Generic Product Selection Law: influence on pharmacy practice.
    Hunter RH
    Med Mark Media; 1979 Jul; 14(7):33-6. PubMed ID: 10243269
    [No Abstract]   [Full Text] [Related]  

  • 16. Control of drug substitution is the real issue.
    Stetler CJ
    J Med Soc N J; 1979 Jun; 76(6):458-9. PubMed ID: 287817
    [No Abstract]   [Full Text] [Related]  

  • 17. Attorney General limits generic drug substitution.
    Hall SL
    Mich Med; 1975 Mar; 74(9):148-9. PubMed ID: 1124017
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapeutic substitution--usurpation of the physician's prerogative.
    Ballin JC
    JAMA; 1987 Jan 23-30; 257(4):528-9. PubMed ID: 3795436
    [No Abstract]   [Full Text] [Related]  

  • 19. The substitution issue.
    Archambault GF
    Drug Intell Clin Pharm; 1982 Oct; 16(10):803-4. PubMed ID: 7140519
    [No Abstract]   [Full Text] [Related]  

  • 20. On therapeutic equivalency and the antisubstitution laws.
    Schiffman DO
    JAMA; 1973 Jan; 223(5):552-3. PubMed ID: 4739142
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.